Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 28;7(2):99-105.
doi: 10.14218/JCTH.2019.00010. Epub 2019 May 4.

Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population

Yuan Li  1 , Shousheng Liu  2   3 , Yuqiang Gao  1 , Huan Ma  1 , Shuhui Zhan  1 , Yan Yang  1 , Yongning Xin  1   4   3 , Shiying Xuan  1   3
Affiliations

Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population

Yuan Li et al. J Clin Transl Hepatol. .

Abstract

Background and Aims: Colorectal cancer is associated with non-alcoholic fatty liver disease (NAFLD) and other metabolic syndromes, such as obesity, abnormal blood glucose, and dyslipidemia. The relationship of NAFLD and colorectal adenoma, which is the precursor of colorectal cancer, is worthy of discussion. The aim of this study was to investigate the association between colorectal adenoma and NAFLD, colorectal adenoma and metabolic syndrome in a Chinese Han population. Methods: This retrospective study analyzed the relationship between NAFLD and colorectal adenoma in 1089 patients in Qingdao municipal hospital. Subjects were divided into a colorectal adenoma group (n = 267) and a control group (n = 822). NAFLD and the controlled attenuation parameter (CAP) value were determined by abdominal ultrasound and FibroScan. Results: Patients with NAFLD in the colorectal adenoma group and the control group represented 142 cases (53.2%) and 360 cases (43.8%), respectively. The mean CAP value in the colorectal adenoma group was significantly higher than that in the control group. The values of body mass index, triglyceride, high-density lipoprotein cholesterol, aspartate aminotransferase, fasting plasma glucose, and uric acid were also significantly higher in the colorectal adenoma group than in the control group. Multifactor logistic regression analysis showed that the sex, NAFLD, CAP, body mass index, triglyceride, aspartate aminotransferase, and fasting plasma glucose were significant risk factors for colorectal adenoma. Besides, NAFLD and CAP value were significant risk factors for colorectal adenoma in males but not in females. Conclusions: NAFLD and metabolic syndrome were tightly associated with the risk of colorectal adenoma in this Chinese Han population. The effect of NAFLD on colorectal adenoma was prominent in males rather than in females.

Keywords: Colorectal adenoma; Controlled attenuation parameter (CAP); Metabolic syndrome; Non-alcoholic fatty liver disease (NAFLD).

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interests related to this publication.

Figures

Fig. 1.
Fig. 1.. Flowchart of the study participant recruitment process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci (Basel) 2018;6:31. doi: 10.3390/medsci6020031. - DOI - PMC - PubMed
    1. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321:805–808. doi: 10.1136/bmj.321.7264.805. - DOI - PMC - PubMed
    1. Sawbridge D, Probert C. Population-based screening in colorectal cancer-current practice and future developments: faecal biomarkers review. J Gastrointestin Liver Dis. 2014;23:195–202. doi: 10.15403/jgld.2014.1121.232.dsw1. - DOI - PubMed
    1. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649. doi: 10.1136/gutjnl-2014-309086. - DOI - PubMed
    1. Sclafani F, Gullo G, Sheahan K, Crown J. BRAF mutations in melanoma and colorectal cancer: a single oncogenic mutation with different tumour phenotypes and clinical implications. Crit Rev Oncol Hematol. 2013;87:55–68. doi: 10.1016/j.critrevonc.2012.11.003. - DOI - PubMed